Retraction notice to "Myeloid-derived suppressor cells accumulate in the liver site after sepsis to induce immunosuppression" Cellular Immunology 279 (2012) 12-20;Myeloid-derived suppressor cells accumulate in the liver site after sepsis to induce immunosuppression

Cellular Immunology

Volumn 279, Issue 1, 2012, Pages 12-20

  Ren, Dongping ^a   Bi, Qi ^b   Li, Li ^a   Gao, Yongqiang ^a   Liang, Yu ^a   Li, Yingju ^a   Liu, Jun ^a   Peng, Li ^a   Xiao, Jianhua ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

CLP; Immune suppression; Myeloid derived suppressor cells; Sepsis

Indexed keywords

ACUTE LIVER FAILURE; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LIVER; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SPLEEN; SUPPRESSOR CELL; SURVIVAL RATE; SURVIVAL TIME;

MUS;

EID: 84871669888     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.07.007     Document Type: Erratum

References (28)

1. Gabrilovich D.I., Bronte V., Chen S.H., Colombo M.P., Ochoa A., Ostrand-Rosenberg S., Schreiber H. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007, 67:426.
2. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. Clin. Invest. 2007, 117:1155-1166.
3. Massberg S., Schaerli P., Knezevic-Maramica I., Köllnberger M., Tubo N., Moseman E.A., Huff I.V., Junt T., Wagers A.J., Mazo I.B., von Andrian U.H. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007, 131:994-1008.
4. Zea A.H., Rodrigurez P.C., Atkins M.B., Hernandez C., Signoretti S., Zabaleta J., McDermott D., Quiceno D., Youmans A., O'Neill A., Mier J., Ochoa AC. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005, 65:3044-3048.
5. + Myeloid suppressor cells cause T cell Dysfunction after Traumatic stress. J. Immunol. 2006, 176:2085-2094.
6. + population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 2007, 204:1463-1474.
7. Highfill S.L., Rodriguez P.C., Zhou Q., Goetz C.A., Koehn B.H., Veenstra R., Taylor P.A., Panoskaltsis-Mortari A., Serody J.S., Munn D.H., Tolar J., Ochoa A.C., Blazar B.R. Bone marrow myeloid-derived suppressor cells (MDSC) inhibit graft-versushost disease (GVHD) via an arginase-1 dependent mechanism that is upregulated by IL-13. Blood 2010, 116:5738-5747.
8. De Wilde V., Van Rompaey N., Hill M., Lebrun J.F., Lemaître P., Lhommé F., Kubjak C., Vokaer B., Oldenhove G., Charbonnier L.M., Cuturi M.C., Goldman M., Le Moine A. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am. J. Transplant. 2009, 9:2034-2047.
9. Mazzoni A., Bronte V., Visintin A., Spitzer J.H., Apolloni E., Serafini P., Zanovello P., Segal D.M. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 2002, 168:689-695.
10. Greifenberg V., Ribechini E., Rossner S., Lutz M.B. Myliod-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development. Eur. J. Immunol. 2009, 39:2865-2876.
11. 1. J. Immunol. 2009, 182:240-249.
12. Serafini P., Mgebroff S., Noonan K., Borrello I. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 2008, 68:5439-5449.
13. + T cells. J. Clin. Invest. 2006, 116:2777-2790.
14. + myeloid cells. Cancer Res. 2006, 66:6807-6815.
15. Huang B., Pan P.Y., Li Q., Sato A.I., Levy D.E., Bromberg J., Divino C.M., Chen S.H. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006, 66:1123-1131.
16. Maier S., Traeger T., Entleutner M., Westerholt A., Kleist B., Hüser N., Holzmann B., Stier A., Pfeffer K., Heidecke C.D. Cecal ligation and puncture versus colon ascendens stent peritonitis two distinct animal models for polymicrobial sepsis. Shock 2004, 21:505-511.
17. Rittirsch D., Huber-Lang M.S., Flierl M.A., Ward P.A. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 2009, 4:31-36.
18. Lagasse E., Weissman I.L. Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods 1996, 197:139-150.
19. Quah B.J., Warren H.S., Parish C.R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2007, 2:2049-2056.
20. Sawanobori Y., Ueha S., Kurachi M., Shimaoka T., Talmadge J.E., Abe J., Shono Y., Kitabatake M., Kakimi K., Mukaida N., Matsushima K. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 2008, 111:5457-5466.
21. Morales J.K., Kmieciak M., Knutson K.L., Bear H.D., Manjili M.H. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1-bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res. Treat. 2010, 123:39-49.
22. GRP1. Blood 2010, 115:3970-3979.
23. Slaney C.Y., Toker A., La Flamme A., Bäckström B.T., Harper J.L. Naïve blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunity. Immunol. Cell Biol. 2011, 89:7-13.
24. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
25. + regulatory myeloid cells suppress allergen-induced airway inflammation. Int. Immunopharmacol. 2011, 11:827-832.
26. Veltman J.D., Lambers M.E., van Nimwegen M., Hendriks R.W., Hoogsteden H.C., Aerts J.G., Hegmans J.P. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma Celecoxib influences MDSC function. BMC Cancer 2010, 10:464.
27. Corzo C.A., Cotter M.J., Cheng P., Cheng F., Kusmartsev S., Sotomayor E., Padhya T., McCaffrey T.V., McCaffrey J.C., Gabrilovich D.I. Mechanism regulating reactive oxygen species in tumor induced myeloid-derived suppressor cells: MDSC and ROS in cancer. J. Immunol. 2009, 182:5693-5701.
28. Kusmartsev S., Gabrilovich D.I. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol. Immunother. 2006, 55:237-245.